[{"uuid": "cbcd4b62-0475-3202-aadb-12b0f91081b9", "title": "EcoEngineers Expands Accreditation and Scope Extensions Internationally", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/ecoengineers-expands-accreditation-scope-extensions-081300713.html", "providerPublishTime": 1738656780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ufoSQlbJQEjoSaCGEPWfRg--~B/aD0zMjQ2O3c9NjI0NTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/77ab40363da1abb833701a14d2e94a8c", "width": 6245, "height": 3246, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/n03JdNfXVdDMxp9nqrh.jw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/77ab40363da1abb833701a14d2e94a8c", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "c2a37070-e33f-38a3-9511-756206c605c3", "title": "Anaptys to Present at the Guggenheim SMID Cap Biotech Conference", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/anaptys-present-guggenheim-smid-cap-211500699.html", "providerPublishTime": 1738617300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/FZvV_X_wA1oXvg1Jqozz5g--~B/aD01ODA7dz0yMDU0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/26b15ab2be88eed923b5df1f83897b3e", "width": 2054, "height": 580, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/SfS9uarw6LDoVCkmfvURAQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/26b15ab2be88eed923b5df1f83897b3e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANAB"]}, {"uuid": "8947bda4-6925-342c-81d1-0891d58c2b3e", "title": "Vanda Pharmaceuticals, AnaptysBio Sign Global License Agreement for Imsidolimab", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/vanda-pharmaceuticals-anaptysbio-sign-global-133615257.html", "providerPublishTime": 1738589775, "type": "STORY", "relatedTickers": ["VNDA", "ANAB"]}, {"uuid": "cd3644de-bf3f-3941-aaca-556131ff38b9", "title": "Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/vanda-pharmaceuticals-anaptys-announce-exclusive-123000006.html", "providerPublishTime": 1738585800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/7PLRwh8dybmBiQllGXqnRQ--~B/aD0yNjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/743d2f4492e0b465012535111f8b6bc6", "width": 400, "height": 260, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/zixdmv187trRvOsdtnID6g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/743d2f4492e0b465012535111f8b6bc6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["VNDA", "ANAB"]}, {"uuid": "501b65dd-e9dc-34af-98c8-c90b864b21ef", "title": "EcoEngineers Expands Accreditation and Scope Extensions in Canada and Beyond", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/ecoengineers-expands-accreditation-scope-extensions-180200556.html", "providerPublishTime": 1738173720, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JLbcwnKpV4JbM2ya0BQdwg--~B/aD0zMjA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f0a1cbd720346d915a2c4c036404e3cf", "width": 480, "height": 320, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/89cHMHu7IVEPxvRHZemMWA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f0a1cbd720346d915a2c4c036404e3cf", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "bb389f74-2c06-3824-a1d8-0a8de784ef51", "title": "Are Medical Stocks Lagging  AnaptysBio (ANAB) This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/medical-stocks-lagging-anaptysbio-anab-144006165.html", "providerPublishTime": 1737988806, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/eeFsK50..hTdRBoBNDEyoA--~B/aD03MTE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b", "width": 900, "height": 711, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/U.GeD2pq81ETtKFpwtAvMA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/d2f7ed3d1940141716bfd200f5c94c6b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANAB", "INSP"]}, {"uuid": "05a0a14b-c7f7-3fd3-a1c9-48cce6e93c3d", "title": "Collibra Strengthens AI Governance Leadership with ISO 42001 Certification, AI Pact Commitment and the Delivery of the EU AI Act Assessment Tool", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/collibra-strengthens-ai-governance-leadership-180000657.html", "providerPublishTime": 1737568800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/qd3QFwQfflriaOJ0W73ZpQ--~B/aD0xMDU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5ac17ae5186bf68e4cb13a80b83fded4", "width": 400, "height": 105, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/RW6CU5UfwqgdHv93GVcx1A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/5ac17ae5186bf68e4cb13a80b83fded4", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "88175940-6026-3046-afcf-686d0891449e", "title": "GSK's Jemperli Gets EU Nod for Expanded Use in Endometrial Cancer", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/gsks-jemperli-gets-eu-nod-143500485.html", "providerPublishTime": 1737470100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/KEj1lCkxRqndrrMrF3m.HA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/L9oXp_PBujUXs0r0RIkKrg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c7450ec9df154559fbeb393640d6629", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "17d34dbe-2ddb-3d2a-9e03-f5a2ee9b6ae3", "title": "How AnaptysBio (ANAB) Stock Stands Out in a Strong Industry", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/anaptysbio-anab-stock-stands-strong-144200464.html", "providerPublishTime": 1736779320, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IYksUEF.ZX5JOPFmQ194jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANAB"]}, {"uuid": "dc3f81b4-9150-36a1-8eaa-b3a26d5b29a8", "title": "Big Biotech Fund Loads Up on a Stock That Surged in 2024, and a Loser", "publisher": "Barrons.com", "link": "https://finance.yahoo.com/m/dc3f81b4-9150-36a1-8eaa-b3a26d5b29a8/big-biotech-fund-loads-up-on.html", "providerPublishTime": 1736668800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/_kc6REYMS1JrAuV5bYtjfA--~B/aD02NTt3PTMyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 320, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5waH37HKuL3X52B3V2GWrw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/12ea0f43d8f8307249a68d1cb2e0587e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ANAB"]}, {"uuid": "6d4925cf-d80c-3235-b520-2c2c0c4472f5", "title": "Are Medical Stocks Lagging  United Therapeutics (UTHR) This Year?", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/medical-stocks-lagging-united-therapeutics-144005673.html", "providerPublishTime": 1736433605, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xopQugjeNyS1VO21qlHkcQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f", "width": 900, "height": 675, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/rm3.DEH2cLu6ucaTWn4tQA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["UTHR", "ANAB"]}, {"uuid": "6883fd92-6355-3c16-bcc7-65c3f9341d6e", "title": "NVIDIA Corporation (NVDA) Unveils DRIVE Hyperion with Key Safety and Cybersecurity Certifications for Autonomous Vehicles", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/nvidia-corporation-nvda-unveils-drive-171311634.html", "providerPublishTime": 1736529191, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TTeuFy5Yw2gv7xivFvRsTg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aa94e059977d3251b8b0630718e013fc", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/TZeknJ_fhN5h4AGoB8ZDOg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aa94e059977d3251b8b0630718e013fc", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["NVDA", "^GSPC"]}]